Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Long Term Debt 2019–2025
Recursion Pharmaceuticals, Inc. annual/quarterly long term debt history from 2021 to 2021. Long term debt refers to financial obligations that are due more than one year in the future.
- Recursion Pharmaceuticals, Inc. long term debt for the quarter ending December 31, 2021 were 723,000.
- Recursion Pharmaceuticals, Inc. long term debt for 2021 were 723,000.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Recursion Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2021 | $1 |
| Recursion Pharmaceuticals, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2021-12-31 | $1 |
Recursion Pharmaceuticals, Inc. Long Term Debt — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) long term debt over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's long term debt history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.